Product Program year 2025 Source: CMS Open Payments

PleurX

Device Vascular/Oncology

PDI 10885403420528

Open in the dashboard

General payments

$245,378

215 payments

Research payments

$0

0 payments

Through program year 2025, $245,378 in general payments and $0 in research payments were reported against PleurX (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $7,975 213
2024 General $237,403 2

Breakdown

Who paid General payments · program years 2024–2025
  1. Bard Peripheral Vascular, Inc. $173,030 114 payments
  2. Davol Inc. $68,723 1 payment
  3. Becton, Dickinson and Company $3,342 97 payments
  4. C. R. Bard, Inc. & Subsidiaries $284 3 payments
Top recipients General payments · program year 2025
  1. Steven Sauk Vascular & Interventional Radiology · Saint Louis, MO $742 9% · 3 payments
  2. Jeffrey Thiboutot Internal Medicine · Baltimore, MD $304 4% · 3 payments
  3. Angela Argento Pulmonary Disease · Baltimore, MD $304 4% · 3 payments
  4. Frank Detterbeck Thoracic Surgery (Cardiothoracic Vascular Surgery) · New Haven, CT $242 3% · 2 payments
  5. Yaron Gesthalter Critical Care Medicine · San Francisco, CA $242 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $1,791 23% · 32 practitioners
  2. Diagnostic Radiology Radiology $1,575 20% · 47 practitioners
  3. Pulmonary Disease Internal Medicine $1,202 15% · 12 practitioners
  4. Physician Assistant $775 10% · 27 practitioners
  5. Internal Medicine $652 8% · 8 practitioners

The top 5 of 29 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $1,563 20% · 22 recipients
  2. Illinois $1,365 17% · 29 recipients
  3. Missouri $764 10% · 2 recipients
  4. Ohio $722 9% · 29 recipients
  5. Pennsylvania $505 6% · 8 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

215 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record